Respiratory manifestations of long COVID

References

• Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. COVID-19 Dashboard. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed December 19, 2022.
   Google Scholar
• Public Health Agency of Canada. COVID-19 daily epidemiology update. https://health-infobase.canada.ca/covid-19/?stat=num&measure=deaths_total&map=pt#a2. Accessed December 19, 2022.
   Google Scholar
• Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021;268:113426. doi:10.1016/j.socscimed.2020.113426.
   Google Scholar
• World Health Organization. Coronavirus disease (COVID-19): Post COVID-19 condition. http://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition. 2021. Accessed November 25, 2022.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Post-COVID Conditions: Information for Healthcare Providers. http://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. 2022.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Scottish Intercollegiate Network (SIGN) & Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www-nice-org-uk.myaccess.library.utoronto.ca/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. Accessed November 25, 2022.
   Google Scholar
• Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi:10.1038/s41467-022-29521-z.
   Google Scholar
• Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. 2022;32(4):e2315. doi:10.1002/rmv.2315.
   Google Scholar
• Ballering AV, Zon SKR, van Hartman TC, Olde Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. The Lancet. 2022;400(10350):452–461. doi:10.1016/S0140-6736(22)01214-4.
   Google Scholar
• Taquet M, Dercon Q, Luciano S, et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.
   Google Scholar
• Hernandez-Romieu AC, Carton TW, Saydah S, et al. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. JAMA Netw Open. 2022;5(2):e2147053. doi:10.1001/jamanetworkopen.2021.47053.
   Google Scholar
• Deuel JW, et al. Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo). Lancet Infect. Dis. 2022;22(12):1694–1702.
   Google Scholar
• Evans RA, McAuley H, Harrison EM, PHOSP-COVID Collaborative Group, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275–1287.
   Google Scholar
• Global Burden of Disease Long COVID Collaborators. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604–1615.
   Google Scholar
• Sørensen AIV, Spiliopoulos L, Bager P, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13(1):4213.
   Google Scholar
• Gao P, Liu J, Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. IJERPH. 2022;19(19):12422. doi:10.3390/ijerph191912422.
   Google Scholar
• Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398–2405. doi:10.1038/s41591-022-02051-3.
   Google Scholar
• Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. The Lancet. 2022;399(10343):2263–2264. doi:10.1016/S0140-6736(22)00941-2.
   Google Scholar
• Bach K. New data shows long Covid is keeping as many as 4 million people out of work. Brookings. https://www.brookings.edu/research/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/. Accessed November 25, 2022.
   Google Scholar
• Natarajan A, Zlitni S, Brooks EF, et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y). 2022;3(6):371–387.e9. doi:10.1016/j.medj.2022.04.001.
   Google Scholar
• Zollner A, Koch R, Jukic A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495–506.e8.
   Google Scholar
• Brodin P, Casari G, Townsend L, COVID Human Genetic Effort, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879–882.
   Google Scholar
• Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci U S A. 2020;117(41):25254–25262. doi:10.1073/pnas.2010722117.
   Google Scholar
• Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J. 2022;:2200970. doi:10.1183/13993003.00970-2022.
   Google Scholar
• Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. doi:10.1126/scitranslmed.abd3876.
   Google Scholar
• Wang EY, Mao T, Klein J, Yale IMPACT Team, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283–288.
   Google Scholar
• Aiyegbusi OL, Hughes SE, Turner G, TLC Study Group, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428–442.
   Google Scholar
• Aranda J, Oriol I, Martín M, et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J Infect. 2021;83(5):581–588. doi:10.1016/j.jinf.2021.08.018.
   Google Scholar
• So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med. 2021;21(1):97. doi:10.1186/s12890-021-01463-0.
   Google Scholar
• Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.
   Google Scholar
• Blomberg B, Mohn KG-I, Brokstad KA, Bergen COVID-19 Research Group, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607–1613. doi:10.1038/s41591-021-01433-3.
   Google Scholar
• Abdallah SJ, Voduc N, Corrales-Medina VF, et al. Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19. Ann Am Thorac Soc. 2021;18(11):1912–1917.
   Google Scholar
• van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5):e1089–e1098.
   Google Scholar
• Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 2021;21(10):1373–1382. doi:10.1016/S1473-3099(21)00211-5.
   Google Scholar
• Su Y, Yuan D, Chen DG, ISB-Swedish COVID-19 Biobanking Unit, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881–895.e20.
   Google Scholar
• Kanczkowski W, Beuschlein F, Bornstein SR. Is there a role for the adrenal glands in long COVID? Nat Rev Endocrinol. 2022;18(8):451–452. doi:10.1038/s41574-022-00700-8.
   Google Scholar
• Matheson AM, McIntosh MJ, Kooner HK, et al. Persistent 129Xe MRI pulmonary and CT vascular abnormalities in symptomatic individuals with post-acute COVID-19 syndrome. Radiology. 2022;305(2):466–476. doi:10.1148/radiol.220492.
   Google Scholar
• Lopes AJ, Mafort TT, da Cal MS, et al. Impulse oscillometry findings and their associations with lung ultrasound signs in COVID-19 survivors. Respir Care. 2021;66(11):1691–1698.
   Google Scholar
• Nehme M, Braillard O, Salamun J, et al. Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J Gen Intern Med. 2022;37(6):1585–1588. doi:10.1007/s11606-022-07443-2.
   Google Scholar
• Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi:10.1136/bmj-2021-069676.
   Google Scholar
• Xie Y, Choi T, Al-Aly Z. Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19. 2022. doi:10.1101/2022.11.03.22281783.
   Google Scholar
• Nopp S, Moik F, Klok FA, et al. Outpatient pulmonary rehabilitation in patients with long covid improves exercise capacity, functional status, dyspnea, fatigue, and quality of Life. Respiration. 2022;101(6):593–601. doi:10.1159/000522118.
   Google Scholar
• Beauchamp MK, et al. Canadian thoracic society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation. Can. J. Respir. Crit. Care Sleep Med. 2022;6:9–13.
   Google Scholar
• Ledford H. Long-COVID treatments: why the world is still waiting. Nature. 2022;608(7922):258–260. doi:10.1038/d41586-022-02140-w.
   Google Scholar
• Kouri A, Gupta S, Yadollahi A, et al. CHEST reviews. Addressing Reduced Laboratory-Based Pulmonary Function Testing during a Pandemic. CHEST. 2020;158(6):2502–10.
   Google Scholar
• Government Of Canada, Canadian institute of health research. Notice of an upcoming Canadian Post COVID-19 Condition Research Network funding opportunity. https://cihr-irsc.gc.ca/e/53186.html. Accessed November 25, 2022.
   Google Scholar
• CANCOV – The Canadian COVID-19 Prospective Cohort Study. https://cancov.net/. Accessed November 25, 2022.
   Google Scholar
• Gershon A. The Canadian respiratory research network long COVID-19 study. https://clinicaltrials.gov/ct2/show/NCT05181670. Accessed November 25, 2022.
   Google Scholar